Jeffrey J. Swigris, DO; Ware G. Kuschner, MD, FCCP; Jennifer L. Kelsey, PhD; and Michael K. Gould, MD, MS, FCCP

HTML
DOWNLOAD

Μέγεθος: px

Εμφάνιση ξεκινά από τη σελίδα:

Download "Jeffrey J. Swigris, DO; Ware G. Kuschner, MD, FCCP; Jennifer L. Kelsey, PhD; and Michael K. Gould, MD, MS, FCCP"

Ἀμών Βυζάντιος
6 χρόνια πριν
Προβολές:

1 Jeffrey J. Swigris, DO; Ware G. Kuschner, MD, FCCP; Jennifer L. Kelsey, PhD; and Michael K. Gould, MD, MS, FCCP () (1) (2) (3) CT γ-1b (interstitial); (lung diseases); (pulmonary fibrosis) (idiopathic pulmonary fibrosis ) (idiopathic interstitial pneumonias IIPs) (nonspecific interstitial pneumonia NSIP) [1] < 3 y 316

2 1 NSIP NSIP ( IIP ) NSIP NSIP (interstitial lung diseases IIP) IIPs [2] UIP / [2] ( / UIP) 7 (1) (2) NSIP [3] (3) (4) (5) UIP UIP / (6) (7) ( 1) CT (high-resolution CT HRCT) UIP [ (usual UIP interstitial pneumonia UIP)] / / ( ) IIP UIP UIP From the Division of Pulmonary and Critical Care Medicine (Dr. Swigris), Stanford University, Stanford; Veterans Affairs Palo Alto Health Care System (Drs. Kuschner and Gould), PaloAlto; and Division of Epidemiology (Dr. Kelsey), Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA. Correspondence to: Jeffrey J. Swigris, DO, Stanford University Medical Center, Division of Pulmonary and Critical Care Medicine, MC5236, Room #3143, 300 Pasteur Dr, Stanford, CA ; jswigris@stanford. edu UIP ( ) UIP UIP CHEST

3 ( NSIP ) NSIP / % NSIP NSIP NSIP / y Katzenstein [4] 1994 NSIP 1 (UIP) NSIP IIP Bjoraker [7] NSIP IIP [5,6,8,9] UIP NSIP ( 1) UIP NSIP [4] NSIP ( NSIP ) ( NSIP ) NSIP ( 1) NSIP [5,6] 1994 NSIP NSIP 1998 NSIP UIP [10] UIP ( NSIP) UIP NSIP Katzenstein [11] 21 NSIP UIP NSIP Bjoraker [7] NSIP UIP NSIP UIP 14% NSIP UIP 5 y 70% 5 y < 30% 24% ~ 36% NSIP NSIP Flaherty [10] UIP ( ) UIP 318

4 NSIP 2 NSIP ( ) UIP NSIP ; NSIP ( FEV 1 / FVC ) ( ); 1994 HRCT ; 13 ~ 20 / [12] BAL > 50 ; [13] ( ) 3 mo NSIP [5,7~9] ( Velco ) [18~20] NSIP ( ) / [17] ( 2) UIP [1~16] 62% 97% UIP UIP [2,3,17] 40% [16] 3 91 UIP HRCT [16] 15% [21] UIP 72% 84% 1 77% (positive predictive value PPV) 87% 79% 87% PPV 87% 50% [16,21] 26 [22] 3 / 30% CHEST

5 HRCT IIP HRCT HRCTs 77% 72% PPV 85% 3 (1) ( (2) 50%) 87% 95% PPV 96% HRCT [25] HRCT [23] HRCT [16] HRCT 3 ~ 5 y [10,14,26~29] [24] [30~32] HRCT (OR P = ) (78% 95%CI 6 min [24] 62% ~ 90%) < 88% HRCT 4 y (OR 5.36 P = 0.007) 35% 69% (OR 6.28 P = 0.004) ( FVC 6 [30] mo ) 81% [32] (95%CI 64% ~ 91%) HRCT HRCT HRCT [33] HRCT (3) Lama [31] 7 mo [1] 320

6 ( ) [34,35] 10% ~ 30% [36] [15,37~40] [5~7] UIP [45] 0% ~ 10% 20% ~ 30% ( ); [41~43] ; UIP 2 / 3 [17,20,44] [46] [17] [41,42] [47] γ ( ) CHEST

7 ( ) [46] [50~52] ( ) ( ) (clinician s choice CC) (equipoisestratified ES) CC [48] CC IIP 1 ( ) ES IIP ( ) NSIP [49] IIP ES CC Lavori [49] 1 Selman M, et al. Ann Intern Med 2001;134: Joint Statement of the American Thoracic Society and the European Respiratory Society: American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir 322

8 Crit Care Med 2002;165: Katzenstein AL, et al. Am J Respir Crit Care Med 1998;157: Katzenstein AL, et al. Am J Surg Pathol 1994;18: Nicholson AG, et al. Am J Respir Crit Care Med 2000;162: Daniil ZD, et al. Am J Respir Crit Care Med 1999;160: Bjoraker JA, et al. Am J Respir Crit Care Med 1998;157: Nagai S, et al. Eur Respir J 1998;12: Travis W, et al. Am J Surg Pathol 2000;24: Flaherty KR, et al. Am J Respir Crit Care Med 2001;164: Katzenstein AL, et al. Am J Surg Pathol 2002;26: Coultas D, et al. Am J Respir Crit Care Med 1994;150: Coultas D, et al. Thorax 1996;51: King TE Jr, et al. Am J Respir Crit Care Med 2001;164: Flaherty KR, et al. Am J Med 2001;110: Hunninghake GW, et al. Am J Respir Crit Care Med 2001;164: Joint Statement of the American Thoracic Society and the European Respiratory Society: idiopathic pulmonary fibrosis: diagnosis and treatment; international consensus statement. Am J Respir Crit Care Med 2000;161: Mapel D, et al. Chest 1996;110: Johnston I, et al. Thorax 1997;52: Johnston ID, et al. Eur Respir J 1993;6: Raghu G, et al. Chest 1999;116: Peckham R, et al. Chest 2002;122:47S 23 MacDonald S, et al. Radiology 2001;221: Hunninghake GW, et al. Chest 2003;124: Laupacis A, et al. JAMA 1997;277: Boomars KA, et al. Thorax 1995;50: Gay S, et al. Am J Respir Crit Care Med 1998;157: King TE Jr, et al. Am J Respir Crit Care Med 2001;164: Nicholson A, et al. Am J Respir Crit Care Med 2002;166: Flaherty KR, et al. Am J Respir Crit Care Med 2003;168: Lama V, et al. Am J Respir Crit Care Med 2003;168: Wells AU, et al. Am J Respir Crit Care Med 2003;167: Adamson I, et al. Am J Pathol 1988;130: Davies H, et al. Cochrane Database of Systematic Reviews 2003;1 35 Richeldi L, et al. Cochrane Database of Systematic Reviews 2003;1 36 Lynch J III, et al. Curr Opin Pulm Med 2001;7: Carrington C, et al. N Engl J Med 1978;298: Turner-Warwick M, et al. Thorax 1980;35: Tukiainen P, et al. Thorax 1983;38: Stack B, et al. Thorax 1972;27: Raghu G, et al. Am Rev Respir Dis 1991;144: Johnson M, et al. Thorax 1989;44: Douglas WW, et al. Mayo Clin Proc 1997;72: Douglas WW, et al. Am J Respir Crit Care Med 2000;161: Johnston ID, et al. Thorax 1997;52: Temple R, et al. Ann Intern Med 2000;133: Raghu G, et al. N Engl J Med 2004;350: Wyse DG, et al. N Engl J Med 2002;347: Lavori P, et al. Biol Psychiatry 2001;50: DeVries J, et al. Eur Respir J 2001;17: DeVries J, et al. Respir Med 2000;94: Martinez T, et al. Chest 2000;117: CHEST 2005;127: CHEST

Σχετικά έγγραφα

Θέσεις & Αντιθέσεις στις Διάμεσες Πνευμονοπάθειες

Θέσεις & Αντιθέσεις στις Διάμεσες Πνευμονοπάθειες Κατερίνα Μανίκα Επιμελήτρια Β Α Πνευμονολογική Κλινική ΓΝΘ «Γ. Παπανικολάου» Θέσεις & Αντιθέσεις στις Διάμεσες Πνευμονοπάθειες Νέες θέσεις ομοφωνίας για